Ingevity (NGVT) Competitors $59.69 +0.81 (+1.38%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$59.76 +0.07 (+0.12%) As of 09/5/2025 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NGVT vs. SCL, AXTA, ESI, CSW, AVNT, PRM, MEOH, PCT, CC, and UANShould you be buying Ingevity stock or one of its competitors? The main competitors of Ingevity include Stepan (SCL), Axalta Coating Systems (AXTA), Element Solutions (ESI), CSW Industrials (CSW), Avient (AVNT), Perimeter Solutions (PRM), Methanex (MEOH), PureCycle Technologies (PCT), Chemours (CC), and CVR Partners (UAN). Ingevity vs. Its Competitors Stepan Axalta Coating Systems Element Solutions CSW Industrials Avient Perimeter Solutions Methanex PureCycle Technologies Chemours CVR Partners Ingevity (NYSE:NGVT) and Stepan (NYSE:SCL) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Do analysts prefer NGVT or SCL? Ingevity currently has a consensus price target of $58.00, suggesting a potential downside of 2.84%. Given Ingevity's stronger consensus rating and higher probable upside, research analysts plainly believe Ingevity is more favorable than Stepan.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ingevity 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Stepan 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has preferable earnings and valuation, NGVT or SCL? Stepan has higher revenue and earnings than Ingevity. Ingevity is trading at a lower price-to-earnings ratio than Stepan, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIngevity$1.41B1.55-$430.30M-$5.95-10.03Stepan$2.18B0.52$50.37M$2.5419.70 Which has more risk and volatility, NGVT or SCL? Ingevity has a beta of 1.44, meaning that its stock price is 44% more volatile than the S&P 500. Comparatively, Stepan has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Does the media favor NGVT or SCL? In the previous week, Ingevity had 10 more articles in the media than Stepan. MarketBeat recorded 12 mentions for Ingevity and 2 mentions for Stepan. Ingevity's average media sentiment score of 0.99 beat Stepan's score of 0.56 indicating that Ingevity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ingevity 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Stepan 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is NGVT or SCL more profitable? Stepan has a net margin of 2.57% compared to Ingevity's net margin of -16.35%. Ingevity's return on equity of 84.92% beat Stepan's return on equity.Company Net Margins Return on Equity Return on Assets Ingevity-16.35% 84.92% 7.95% Stepan 2.57%4.78%2.42% Do institutionals and insiders hold more shares of NGVT or SCL? 91.6% of Ingevity shares are owned by institutional investors. Comparatively, 82.7% of Stepan shares are owned by institutional investors. 1.1% of Ingevity shares are owned by company insiders. Comparatively, 6.9% of Stepan shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryIngevity beats Stepan on 10 of the 16 factors compared between the two stocks. Get Ingevity News Delivered to You Automatically Sign up to receive the latest news and ratings for NGVT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NGVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NGVT vs. The Competition Export to ExcelMetricIngevityCHEM IndustryMaterials SectorNYSE ExchangeMarket Cap$2.18B$15.74B$3.55B$21.37BDividend YieldN/A1.85%5.06%3.49%P/E Ratio-10.0354.02157.3229.62Price / Sales1.553.1413,757.2369.52Price / Cash3.7113.5324.2525.18Price / Book11.123.316.484.55Net Income-$430.30M$423.39M$149.66M$999.70M7 Day Performance2.36%0.59%2.61%0.58%1 Month Performance22.11%10.21%10.13%5.66%1 Year Performance68.82%14.22%48.72%17.40% Ingevity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NGVTIngevity2.487 of 5 stars$59.69+1.4%$58.00-2.8%+63.2%$2.18B$1.41B-10.031,600News CoverageAnalyst ForecastSCLStepan3.8464 of 5 stars$50.16-0.2%N/A-31.5%$1.13B$2.18B19.752,396AXTAAxalta Coating Systems4.4839 of 5 stars$31.24+0.9%$37.71+20.7%-9.2%$6.77B$5.28B15.3112,800News CoveragePositive NewsESIElement Solutions4.1909 of 5 stars$25.71-0.8%$27.38+6.5%+1.2%$6.21B$2.46B25.715,300News CoveragePositive NewsEx-DividendCSWCSW Industrials4.1143 of 5 stars$274.28+0.4%$319.75+16.6%-9.3%$4.60B$878.30M32.772,600Positive NewsAnalyst UpgradeAVNTAvient4.6876 of 5 stars$37.38+0.4%$45.60+22.0%-18.5%$3.42B$3.24B29.219,200News CoveragePositive NewsPRMPerimeter Solutions3.877 of 5 stars$22.37+1.6%$22.50+0.6%+97.7%$3.28B$560.97M52.03240News CoveragePositive NewsMEOHMethanex4.2604 of 5 stars$35.51-0.6%$44.88+26.4%-14.1%$2.75B$3.72B10.471,415Positive NewsPCTPureCycle Technologies2.6456 of 5 stars$14.29-2.3%$15.00+5.0%+147.5%$2.57BN/A-8.46120News CoveragePositive NewsCCChemours3.1774 of 5 stars$15.38+2.1%$17.38+13.0%-15.5%$2.31B$5.78B-5.496,600Positive NewsUANCVR Partners1.967 of 5 stars$89.68-0.9%N/A+30.4%$1.54B$525.32M10.78300Positive News Related Companies and Tools Related Companies SCL Competitors AXTA Competitors ESI Competitors CSW Competitors AVNT Competitors PRM Competitors MEOH Competitors PCT Competitors CC Competitors UAN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NGVT) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3 Major A.I. Threats That Could Upend the U.S. EconomyThe media's calling Artificial Intelligence a "revolution," but for many Americans, the real impact might actu...Goldco Precious Metals | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ingevity Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Ingevity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
